查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835371

术中影像市场（按模式、组件、应用和最终用户划分）—2025-2032 年全球预测

Intraoperative Imaging Market by Modality, Component, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，术中成像市场将成长至 70.8 亿美元，复合年增长率为 6.97%。

主要市场统计数据
基准年2024年 41.3亿美元
预计2025年 44.2亿美元
预测年份：2032年 70.8亿美元
复合年增长率（%） 6.97%

策略性介绍，阐述推动现代外科护理中采用术中影像的临床要求、技术推动因素和组织优先事项

术中影像学处于技术创新与临床需求的交汇点，从根本上改变了外科医师可视化解剖结构、确认切缘和降低手术风险的方式。影像解析度、即时重建和模态融合技术的进步，将先前仅限于放射科的功能转移到了手术室，从而实现了更精准、数据主导的干预。同时，医疗保健服务也发生了变化，包括门诊手术中心的兴起、缩短时间的压力以及对经济高效的手术全期工作流程的需求，这些都加速了基于影像处理的手术路径的采用和重新设计。

临床医生和医院领导如今要求系统能够与电子健康记录无缝集成，提供强大的互通性，并提供检验的临床工作流程，从而显着改善治疗效果。同时，用于影像增强和自动测量的人工智慧等软体主导功能正在从先导计画转向商业产品的组成部分。因此，产品开发的重点集中在模组化硬体平台、扩充性的软体生态系统以及支援培训、维护和迭代软体更新的服务模式。本引言将重点放在影响术中影像投资采购决策和长期策略规划的临床需求、技术推动因素和组织驱动因素，为后续分析提供组装。

创新技术和营运转变正在融合，以创建一个整合的、以软体为中心的术中成像生态系统，从而优化临床结果和工作流程

术中影像领域正在经历一场变革性的转变，这正在重新定义外科团队规划、执行和检验手术流程的方式。一个关键的转变是各种成像模式向混合平台的融合，这些平台允许在手术过程中同时或依次使用 CT（电脑断层扫描）、透视、MRI（磁振造影）和高解析度超音波。这种融合支援多平面可视化，并能够即时决策，从而缩短手术时间并降低再次手术的风险。在硬体融合的同时，软体主导的创新也正在实现高级视觉化、抗蚀剂和人工智慧辅助读取，这些共同促成了以精准度和可重复性为中心的全新临床工作流程。

另一个重大变化涉及手术环境本身。混合手术室和增强型门诊手术环境正在成为常态，迫使设备製造商和医疗系统重新考虑其空间布局、无菌工作流程和培训计划。此外，基于价值的报销和绩效指标正促使相关人员优先考虑那些能够对病患吞吐量、安全性和手术效果产生可衡量影响的解决方案。供应链韧性和监管协调正在成为影响供应商选择和伙伴关係模式的策略考量。总而言之，这些变化标誌着市场正在从孤立的影像处理工具转向整合的、以软体为中心的生态系统，旨在为广泛的专业领域提供一致的临床效用。

2025 年对进口诊断影像组件征收的关税如何鼓励外科手术提供者进行本地製造、供应链多元化和战略采购

2025年生效的关税将影响医疗影像组件及相关子系统的进口，并对整个术中影像处理价值链产生了一系列营运和战略影响。关键次组件和成像主机的关税上调导致采购预算紧张，迫使医疗系统和设备製造商重新评估供应商合约和总拥有成本假设。为此，一些製造商加快了本地化进程，实现了供应商多元化，并重新协商了零件采购，以降低进口关税风险和潜在的前置作业时间波动。

在营运方面，供应链经理优先考虑关键备件和耗材的库存缓衝，服务机构则调整维护计划和备件策略，以应对更长的补货週期。对于临床团队而言，由关税主导的医疗设备成本凸显了透过比较有效性数据和程序效率来证明医疗设备效用的重要性。监理机关和采购部门更紧密合作，评估生命週期成本，不仅考虑购置价格，还考虑服务、培训和软体更新承诺。总而言之，这些动态有利于拥有强大区域製造地、成熟售后支援和灵活商业性安排的供应商，从而促进了战略伙伴关係关係，旨在即使在贸易壁垒不断变化的情况下也能保持对先进影像处理能力的获取。

深度细分主导的洞察，连接模态选择、组件生命週期、临床使用和护理环境，为您的术中成像产品和服务策略提供信息

細項分析揭示了临床环境和采购途径在技术和服务采用方面存在的重要细微差别。就诊方式而言，该领域涵盖电脑断层扫描、柔性和刚性内视镜检查、萤光透视、磁振造影和超音波。每种方式都有不同的基础设施需求、人员配备影响以及灭菌工作流程，这些因素会影响采购决策和手术室设计。柔性内视镜平台因其可操作性和手术吞吐量优势，通常是门诊和微创手术的首选，而硬式内视镜在需要结构刚性和光学性能的专科领域仍然占据核心地位。

考虑组件级细分突显了经营模式的差异。设备采购具有资本规划影响，而服务（分为维护和培训）代表持续的营运承诺，可在整个生命週期中推动价值。软体正日益成为一种差异化因素，它提供互通性、影像配准和分析功能，可扩展硬体的临床效用。应用细分进一步阐明了临床需求模式。心血管外科、一般外科、神经外科、整形外科和泌尿系统对影像引导的准确性、术中导航和模态选择都有独特的需求。门诊手术中心优先考虑支援高吞吐量的紧凑、经济高效的系统，而医院通常需要多重模式平台和先进的支援服务来满足复杂的病例组合和监管要求。这种分层细分观点可帮助相关人员将产品设计、服务产品和商业策略与特定的临床和操作用例结合。

美洲、欧洲、中东和非洲地区以及亚太地区的采用模式和供应链动态将塑造差异化的市场策略和临床检验路径

区域动态显着影响术中影像的技术采用、采购偏好和监管格局。在美洲，医疗体系的整合和对价值导向医疗的关注，正在推动对那些展现出高效操作和可衡量临床效益的系统的投资。该地区的私人和公共采购商通常需要强大的服务网络和全面的培训计划，以支援广泛的临床部署。相较之下，欧洲、中东和非洲 (EMEA) 地区的政策环境多样，法律规范和报销模式也存在显着差异，这迫使供应商采用针对特定地区的临床检验策略和灵活的商业条款，以在每个医疗保健市场中获得发展。

在亚太地区，由于产能扩张、政府主导的三级医疗机构投资以及国内製造能力的提升，创新治疗方法正在特定市场迅速普及。在每个地区，供应链和当地监管部门的核准都会影响产品上市时间和全生命週期支援。这些地理差异凸显了专业化的上市策略、量身定制的临床证据以及对本地服务基础设施的投资的重要性，这些倡议有助于支持术中成像技术的推广和长期使用。

产品模组化、软体平台和卓越服务正成为手术影像处理环境中长期采用的决定性竞争因素。

术中成像领域的竞争态势由硬体创新、软体生态系统和卓越服务的相互作用所驱动。领先的设备供应商正日益寻求透过模组化设计实现差异化，以实现现场升级和跨模态集成，从而在保护装置量价值的同时，为先进的影像处理功能创造追加提升销售机会。软体供应商正在寻求与硬体製造商和医疗保健系统建立伙伴关係，将分析、配准和影像融合功能直接嵌入到临床工作流程中，从而将其价值提案从以设备为中心的销售模式转变为以平台为中心的经常性收益模式。

提供全面临床教育、快速维护和结果支援服务的公司往往深深植根于复杂的医院环境。原始设备製造商 (OEM)、软体开发人员和临床中心之间的发展加速了证据生成，并使得快速采用新的术中工作流程成为可能。此外，策略性合作伙伴关係（包括共同开发契约、OEM-供应商整合和有针对性的收购）是确保技术力、区域市场进入和售后市场收益的常用伙伴关係。政府和监管机构仍然是产品引进的关键安全隔离网闸，因此临床检验和上市后调查计画的重要性更高。这些因素共同构成了这样一种格局：技术创新必须与强大的商业化和支持模式相匹配，才能实现持续的临床整合。

为技术开发人员和医疗保健系统提供可行的策略建议，以协调产品蓝图、服务模式和采购方法，实现永续的术中影像应用

行业领导者应优先考虑平衡的策略，将技术开发与实际部署和支援结构相结合。首先，加快对支援互通性、云端分析和模组化升级的软体平台的投资，确保硬体投资在多个临床週期内保持价值。制定清晰的API策略，并采用基于标准的互通性，以简化与电子健康记录和手术导引套件的集成，减少临床团队之间的摩擦。其次，扩大区域製造和分销能力，以降低贸易政策风险并缩短前置作业时间。

第三，投资专注于特定手术工作流程、能力评估和结果追踪的综合服务和临床培训项目。第四，寻求有针对性的临床合作伙伴关係，以产生真实世界证据，证明手术效益、安全性和工作流程效率，这是采购委员会和卫生技术评估伙伴关係日益增长的需求。第五，探索灵活的商业模式，例如订阅和结果挂钩定价，以协调供应商和付款人的奖励。最后，保持严谨的併购和伙伴关係策略，专注于收购互补的软体能力和区域支援资产，而不是重迭的硬体产品组合。这些行动将使您能够在管理营运和监管复杂性的同时，获得术中成像的优势。

采用严格的混合方法研究途径检验对术中成像的见解，该方法整合了临床医生访谈、供应链映射、监管审查和证据三角测量

本执行摘要背后的调查方法将定性一手资料研究与结构化二次分析相结合，以确保研究结果既能反映临床医生的经验，又能反映行业相关信号。一手资料研究包括对外科医生、生物医学工程负责人、采购负责人和临床营运经理的深入访谈，以掌握关于技术性能、培训需求和采购重点的第一手观点。此外，专家圆桌讨论会也对这些访谈进行了补充，探讨了混合手术室设计、手术方式选择和上市后支持策略方面的实际挑战。

二次研究涵盖同行评审的临床文献、监管指南、技术标准和供应商产品文檔，旨在建立客观的医疗器材能力和临床用例​​基准。我们进行了供应链映射，以确定组件依赖关係和区域製造足迹，案例研究分析展示了成功的实施模式并避免了陷阱。研究结果透过跨资料来源进行三角测量，以检验主题并区分孤立观察结果和系统性趋势。最后，分析强调了假设的透明度、访谈通讯协定的严格记录以及资讯来源的审核追踪，以支持报告结论的可重复性和高管层的信心。

总结整合技术、实证部署和灵活的商业化策略将如何决定术中影像实施的成功

术中影像正从一堆分散的工具逐渐发展成为一个紧密结合的临床整合系统，对手术准确性和患者预后有着显着的影响。多模态硬体、先进软体和增强型服务模式的整合，为医院和门诊中心创造了重新思考手术路径和提升价值交付的机会。同时，贸易政策的转变、区域监管差异以及报销优先顺序的演变等外部因素正在重塑筹资策略和供应商选择标准。相关人员，将最有可能从其术中成像投资中获得最大收益。

展望未来，我们预计重点将转向能够透过软体更新、与临床系统的无缝互通性以及强大的售后支援实现迭代改进的平台。积极应对供应链风险并投资于临床医生培训的组织将减少采用过程中的摩擦，并加速实现临床和营运效益。最终，最成功的参与企业将是那些将卓越技术与务实、贴近本地市场的商业化策略相结合，以满足外科团队和医疗系统管理人员实际需求的企业。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 引入人工智慧驱动的影像导引系统，提高手术准确性并缩短手术时间
  • 将扩增实境平台与术中影像结合，实现跨多个专业的即时解剖视觉化
  • 可携式照护现场影像设备的出现提高了门诊手术中心的可及性
  • 多模态影像技术的进步，结合了超音波-CT、MRI 和萤光成像技术，使得在手术过程中对组织特征进行全面评估成为可能
  • 开发微创术中影像探头以改善肿瘤手术过程中的肿瘤边缘检测
  • 云端基础中影像资料管理解决方案的成长，促进了远端协作和进阶分析
  • 近期监管部门核准的新型萤光成像剂扩大了血管和神经系统可视化的术中应用

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 术中影像市场（按模式）

  • 电脑断层扫描
  • 内视镜检查
    • 灵活的
    • 死板的
  • 透视
  • 磁振造影
  • 超音波

9. 术中影像市场（按组件）

  • 装置
  • 服务
    • 维护
    • 训练
  • 软体

第 10 章。按应用分類的术中影像市场

  • 心血管系统
  • 一般外科
  • 神经外科
  • 整形外科
  • 泌尿系统

第 11 章。按最终用户分類的术中影像市场

  • 门诊手术中心
  • 医院

第 12 章。按地区分類的术中影像市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章术中影像市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按国家/地区分類的术中影像市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Siemens Healthineers AG
    • GE Healthcare Holdings, Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Medtronic plc
    • Stryker Corporation
    • Shimadzu Corporation
    • Brainlab AG
    • FUJIFILM Holdings Corporation
    • Mindray Medical International Limited
Product Code: MRR-43127F7279EE

The Intraoperative Imaging Market is projected to grow by USD 7.08 billion at a CAGR of 6.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.13 billion
Estimated Year [2025] USD 4.42 billion
Forecast Year [2032] USD 7.08 billion
CAGR (%) 6.97%

A strategic introduction that contextualizes clinical imperatives, technological enablers, and organizational priorities driving intraoperative imaging adoption in modern surgical care

Intraoperative imaging sits at the intersection of technology innovation and clinical demand, fundamentally altering how surgeons visualize anatomy, confirm resection margins, and reduce procedural risk. Advances in image resolution, real-time reconstruction, and modality fusion have migrated capabilities previously confined to radiology suites into the operating room, enabling more precise, data-driven interventions. Concurrent shifts in care delivery-such as the rise of ambulatory surgical centers, pressure to shorten procedure times, and the need for cost-effective perioperative workflows-are accelerating adoption and redesign of imaging-enabled surgical pathways.

Clinicians and hospital leaders are now demanding systems that integrate seamlessly with electronic health records, offer robust interoperability, and provide validated clinical workflows that demonstrably improve outcomes. At the same time, software-driven capabilities such as artificial intelligence for image enhancement and automated measurement are transitioning from pilot projects to components of commercial product offerings. As a result, product development priorities emphasize modular hardware platforms, scalable software ecosystems, and service models that support training, maintenance, and iterative software updates. This introduction frames the subsequent analysis by highlighting clinical imperatives, technology enablers, and organizational drivers that collectively shape procurement decisions and long-term strategic planning for intraoperative imaging investments.

Transformative technological and operational shifts are converging to create integrated, software-centric intraoperative imaging ecosystems that optimize clinical outcomes and workflows

The intraoperative imaging landscape is undergoing transformative shifts that redefine how surgical teams plan, execute, and verify procedures. A primary shift is the convergence of modalities into hybrid platforms that allow simultaneous or sequential use of computed tomography, fluoroscopy, magnetic resonance imaging, and high-resolution ultrasound within the operative setting. This convergence supports multi-planar visualization and enables real-time decision-making that can shorten procedures and reduce the likelihood of revision surgeries. Parallel to hardware convergence, software-led innovation is enabling advanced visualization, registration, and AI-assisted interpretation, which together are unlocking new clinical workflows centered on precision and reproducibility.

Another consequential shift concerns the operating environment itself. Hybrid operating rooms and enhanced ambulatory surgical settings are becoming standardized, prompting equipment manufacturers and health systems to rethink footprints, sterility workflows, and training programs. Additionally, value-based reimbursement and performance metrics are encouraging stakeholders to prioritize solutions that demonstrate measurable impacts on patient throughput, safety, and procedural efficacy. Supply chain resilience and regulatory harmonization are emerging as strategic considerations that influence vendor selection and partnership models. These changes collectively indicate a market moving from siloed imaging tools toward integrated, software-centric ecosystems designed for consistent clinical utility across a broad range of specialties.

How 2025 tariff actions on imported imaging components are prompting localized production, diversified supply chains, and strategic procurement adaptations across surgical providers

The tariff measures enacted in 2025 affecting imports of medical imaging components and associated subsystems have introduced a series of operational and strategic implications across the intraoperative imaging value chain. Increased duties on key subassemblies and imaging consoles have placed pressure on procurement budgets, prompting health systems and device manufacturers to reassess supplier contracts and total cost of ownership assumptions. In response, some manufacturers accelerated localization efforts, diversified supplier bases, and renegotiated component sourcing to mitigate exposure to import tariffs and potential lead-time volatility.

Operationally, supply chain managers prioritized inventory buffering for critical spares and consumables, while service organizations adapted maintenance schedules and spare-parts strategies to address longer replenishment cycles. For clinical teams, tariff-driven device cost inflation highlighted the importance of demonstrating device utility through comparative effectiveness data and procedural efficiency gains. Regulatory and procurement functions worked more closely to evaluate lifecycle costs, considering not only acquisition price but also service, training, and software update commitments. Collectively, these dynamics favored vendors with robust regional manufacturing footprints, established aftermarket support, and flexible commercial arrangements, while catalyzing strategic partnerships aimed at preserving access to advanced imaging capabilities despite shifting trade barriers.

Deep segmentation-driven insights connecting modality choices, component lifecycles, clinical applications, and care settings to inform product and service strategies for intraoperative imaging

Segmentation analysis reveals important nuance in how technologies and services are adopted across clinical contexts and procurement pathways. When considering modality, the field spans computed tomography, endoscopy with both flexible and rigid variants, fluoroscopy, magnetic resonance imaging, and ultrasound; each modality brings distinct infrastructure requirements, staffing implications, and sterilization workflows that inform purchasing decisions and OR design. Endoscopy's flexible platforms are often prioritized for ambulatory and minimally invasive procedures due to their maneuverability and procedural throughput advantages, whereas rigid endoscopes remain central to specialties requiring structural rigidity and optics performance.

Examining component-level segmentation highlights divergent business models: equipment investments coexist with recurring service needs and software lifecycles. Equipment purchases carry capital planning implications, while services-divided into maintenance and training-represent ongoing operational commitments that influence total lifecycle value. Software is increasingly the differentiator, providing interoperability, image registration, and analytics capabilities that extend the clinical utility of hardware. Application segmentation further clarifies clinical demand patterns; cardiovascular procedures, general surgery, neurosurgery, orthopedic interventions, and urology each place unique demands on image-guidance precision, intraoperative navigation, and modality selection. Finally, the end-user segmentation captures differences between ambulatory surgical centers and hospitals: ambulatory settings prioritize compact, cost-efficient systems that support high throughput, whereas hospitals typically require multi-modality platforms and advanced support services to meet complex case mixes and regulatory requirements. These layered segmentation perspectives help stakeholders tailor product design, service offerings, and commercial strategies to specific clinical and operational use cases.

Regional adoption patterns and supply chain dynamics shaping differentiated go-to-market strategies and clinical validation pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly shape technology adoption, procurement preferences, and regulatory interactions across the intraoperative imaging landscape. In the Americas, health system consolidation and a strong emphasis on value-based care are driving investments in systems that demonstrate procedural efficiency and measurable clinical benefits. Private and public purchasers in this region often seek robust service networks and comprehensive training programs to support widespread clinical deployment. In contrast, Europe, Middle East & Africa presents a diverse policy environment where regulatory frameworks and reimbursement models vary widely, prompting vendors to adopt region-specific clinical validation strategies and flexible commercial terms to gain traction across distinct healthcare markets.

Asia-Pacific exhibits rapid uptake of innovative modalities in select markets, supported by capacity expansion, government-led investment in tertiary care centers, and growing domestic manufacturing capabilities. Across regions, supply chain considerations and local regulatory approvals influence time-to-deployment and total lifecycle support commitments. These geographic distinctions underscore the importance of localized go-to-market strategies, tailored clinical evidence generation, and investments in regional service infrastructure to support adoption and long-term utilization of intraoperative imaging technologies.

How product modularity, software platforms, and service excellence are emerging as decisive competitive levers that determine long-term adoption in surgical imaging environments

Competitive dynamics within intraoperative imaging are informed by the interplay of hardware innovation, software ecosystems, and service excellence. Leading equipment providers are increasingly seeking differentiation through modular designs that enable field upgrades and cross-modality integration, thereby protecting installed-base value while creating upsell opportunities for advanced imaging features. Software vendors are pursuing partnerships with hardware manufacturers and healthcare systems to embed analytics, registration, and image-fusion capabilities directly into clinical workflows, shifting the value proposition from device-centric sales to platform-centered, recurring-revenue models.

Service and training excellence are proving to be competitive advantages; companies that offer comprehensive clinical education, responsive maintenance, and outcome-support services tend to achieve deeper penetration in complex hospital environments. Collaboration between OEMs, software developers, and clinical centers accelerates evidence generation, enabling faster adoption of novel intraoperative workflows. Additionally, strategic partnerships-spanning joint development agreements, OEM-supplier consolidation, and targeted acquisitions-are common tactics to secure technological capabilities, regional market access, and aftermarket revenues. Agencies and regulatory bodies remain important gatekeepers for product introductions, increasing the emphasis on clinical validation and post-market surveillance programs. Together, these factors shape a landscape where technical innovation must be matched by robust commercialization and support models to achieve sustained clinical integration.

Actionable strategic recommendations for technology developers and health systems to align product roadmaps, service models, and procurement approaches for sustainable intraoperative imaging adoption

Industry leaders should prioritize a balanced strategy that aligns technology development with pragmatic deployment and support structures. First, accelerate investment in software platforms that enable interoperability, cloud-enabled analytics, and modular upgrades so that hardware investments retain value over multiple clinical cycles. Building a clear API strategy and embracing standards-based interoperability will facilitate integration into electronic health records and surgical navigation suites, reducing friction for clinical teams. Second, expand regional manufacturing and distribution capabilities to mitigate trade-policy risks and shorten lead times; this improves resilience against tariff-driven cost shocks and enhances after-sales responsiveness.

Third, invest in comprehensive service and clinical training programs that emphasize procedure-specific workflows, competency assessments, and outcome tracking; these efforts strengthen clinician confidence and lower barriers to adoption. Fourth, pursue targeted clinical partnerships to generate real-world evidence that demonstrates procedural benefits, safety, and workflow efficiencies-evidence that procurement committees and health technology assessment bodies increasingly require. Fifth, explore flexible commercial models, including subscription and outcome-linked pricing, to align incentives across providers and payers. Finally, maintain a disciplined M&A and partnership strategy focused on acquiring complementary software capabilities and regional support assets rather than duplicative hardware portfolios. Collectively, these actions will position organizations to capture the benefits of intraoperative imaging adoption while managing operational and regulatory complexity.

A rigorous mixed-methods research approach integrating clinician interviews, supply chain mapping, regulatory review, and evidence triangulation to validate intraoperative imaging insights

The research methodology underpinning this executive summary combined qualitative primary research with structured secondary analysis to ensure findings reflect both practitioner experience and contextual industry signals. Primary research included in-depth interviews with surgeons, biomedical engineering leaders, procurement officials, and clinical operations managers to capture first-hand perspectives on technology performance, training needs, and procurement priorities. These interviews were complemented by expert roundtables that explored practical challenges around hybrid operating room design, modality selection, and post-market support strategies.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, technical standards, and vendor product documentation to establish an objective baseline for modality capabilities and clinical use cases. Supply chain mapping exercises identified component dependencies and regional manufacturing footprints, while case study analyses illustrated successful implementation patterns and avoided pitfalls. Findings were triangulated across data sources to validate themes and to differentiate one-off observations from systemic trends. Finally, analysis emphasized transparency in assumptions, rigorous documentation of interview protocols, and an audit trail of sources to support reproducibility and executive-level confidence in the report's conclusions.

Concluding synthesis on how integrated technology, evidence-based deployment, and resilient commercialization strategies will determine success in intraoperative imaging adoption

Intraoperative imaging is maturing from a collection of disparate tools into cohesive, clinically integrated systems that materially influence surgical precision and patient outcomes. The convergence of multimodal hardware, sophisticated software, and enhanced service models is creating opportunities for hospitals and ambulatory centers to reimagine procedural pathways and improve value delivery. At the same time, external forces-such as trade policy shifts, regional regulatory variance, and evolving reimbursement priorities-are reshaping procurement strategies and vendor selection criteria. Stakeholders who align technical innovation with durable service infrastructure and robust clinical evidence will be best positioned to realize the full benefits of intraoperative imaging investments.

Looking ahead, the emphasis will continue to shift toward platforms that enable iterative improvement through software updates, seamless interoperability with clinical systems, and strong aftermarket support. Organizations that proactively address supply chain risks and invest in clinician training will reduce friction in adoption and accelerate realization of clinical and operational benefits. Ultimately, the most successful entrants will be those that pair technological excellence with pragmatic, regionally informed commercialization strategies that answer the real-world needs of surgical teams and health system administrators.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven image guidance systems for enhancing surgical precision and reducing operation times
  • 5.2. Integration of augmented reality platforms with intraoperative imaging for real-time anatomical visualization across multiple specialties
  • 5.3. Emergence of portable point-of-care intraoperative imaging devices improving accessibility in ambulatory surgical centers
  • 5.4. Advances in multimodal imaging combining ultrasound CT MRI and fluorescence modalities for comprehensive intraoperative tissue characterization
  • 5.5. Development of minimally invasive intraoperative imaging probes for enhanced tumor margin detection during oncologic procedures
  • 5.6. Growth of cloud-based intraoperative imaging data management solutions facilitating remote collaboration and advanced analytics
  • 5.7. Recent regulatory approvals of novel fluorescent imaging agents expanding intraoperative applications in vascular and nerve visualization

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative Imaging Market, by Modality

  • 8.1. Computed Tomography
  • 8.2. Endoscopy
    • 8.2.1. Flexible
    • 8.2.2. Rigid
  • 8.3. Fluoroscopy
  • 8.4. Magnetic Resonance Imaging
  • 8.5. Ultrasound

9. Intraoperative Imaging Market, by Component

  • 9.1. Equipment
  • 9.2. Service
    • 9.2.1. Maintenance
    • 9.2.2. Training
  • 9.3. Software

10. Intraoperative Imaging Market, by Application

  • 10.1. Cardiovascular
  • 10.2. General Surgery
  • 10.3. Neurosurgery
  • 10.4. Orthopedic
  • 10.5. Urology

11. Intraoperative Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Intraoperative Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intraoperative Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intraoperative Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Siemens Healthineers AG
    • 15.3.2. GE Healthcare Holdings, Inc.
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Medtronic plc
    • 15.3.6. Stryker Corporation
    • 15.3.7. Shimadzu Corporation
    • 15.3.8. Brainlab AG
    • 15.3.9. FUJIFILM Holdings Corporation
    • 15.3.10. Mindray Medical International Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAOPERATIVE IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAOPERATIVE IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 264. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 265. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 266. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 267. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 268. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 269. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 308. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 309. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 310. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 311. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 312. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 313. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 320. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 321. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 322. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 323. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 324. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 325. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 326. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 327. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES INT